$100m-$499m
Cleerly captures investors’ hearts in $192m series C
Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.
ReCode registers $120m series B extension
UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.
Zap Energy zips to $160m series C
University of Washington spinout Zap Energy is working on building a cheap, scalable fusion reactor generating low cost and carbon free energy.
Finn finds way to $110m series B
UVC Partners has taken part in the round, which will allow Finn to expand further across the US while bolstering its market position in Europe.
Aurion Biotech advances with $120m
Exploiting research conducted at Kyoto Prefecture University of Medicine, Aurion Biotech is focusing on therapies that can restore vision.
Improbable imports $150m in funding
The metaverse technology developer has now pushed its overall funding past $750m since emerging out of Cambridge’s Department of Computer Science and Technology.
Retro looks ahead with $180m
The company, which largely remains in stealth mode, has set itself a mission of increasing the human lifespan by a decade.
Source Global captures $150m
Relying on Arizona State University research, Source Global has developed panels that generate clean drinking water from sunlight and water vapour.
Other News
Affini-T discovers $175m
The co-founders of Fred Hutch's oncology therapeutics developer include Philip Greenberg who previously helped launch Juno Therapeutics.
Jeeves serves up $180m series C
The corporate card provider was valued at $2.1bn in a round backed by Stanford University that increased its funding to $380m altogether.
Triumvira steers series A up to $100m
Triumvera, co-founded by McMaster's professor Jonathan Bramson, looks to progress its solid tumour therapeutic candidate.
SiFive secures $175m series F
UC Berkeley spinout SiFive has fetched a $2.5bn valuation in a series F round that pushed its overall financing to more than $350m.
Scipher Medicine unlocks $110m round
Cowen Healthcare Investments has led a funding round for Scipher Medicine, co-founded by Harvard Medical School colleagues Joseph Loscalzo and Albert-László Barabási.
MindMaze finds way to $105m
EPFL spinout MindMaze has raised $105m from investors including AlbaCore Capital, which had supplied $125m in capital only four months ago.
Editor's Picks
The Standout Six: The deals you need to know about this week
Healthcare companies may be driving a public markets recovery while Lunar Energy, helmed by Tesla's former head of energy, has emerged from stealth with $300m.
SoftBank co-leads $200m CoachHub series C
The digital coaching app developer pushed its overall funding past $330m in a series C round co-led by SoftBank Vision Fund 2.
SoftBank chips into Bucketplace’s $182m round
The owner of home renovation platform Today’s House (Ohouse)’s latest round helped value it at $1.4bn and push its total funding to $261m.
Porsche leads Group14’s $400m series C
Automaker Porsche has led the SK Materials, Amperex, Showa Denko Cabot and BASF-backed EV battery technology provider’s fresh round to help advance the EV industry.